SJR 619 is a non-binding resolution recognizing Tennessee's youth substance abuse crisis, citing data like 29.8% of students vaping nicotine and 13% vaping marijuana per the 2022-2023 Tennessee Together Student Survey. It recommends schools implement evidence-based prevention programs - starting in kindergarten and continuing through graduation - integrated into existing health and physical education curricula. The resolution specifically advocates for life skills training, social-emotional learning, and mental health support as part of these programs. As a statement of intent, it urges the Tennessee Department of Education to adopt these approaches but does not create new laws or allocate funding.
SB 1610 amends Tennessee law to allow Putnam County and incorporated cities within the county meeting specific 2020 census population thresholds (366,200-366,300 for the county, 79,800-79,900 for cities) to regulate sober living homes for substance abuse recovery. The bill enables these local governments to establish rules for such homes while requiring compliance with the Fair Housing Act and Americans with Disabilities Act. It does not create new regulations but defines which jurisdictions can implement them. The key provision adjusts the legal definition of "local government" in state code to include these specific areas.
HB 1949 requires that nonprofit organizations receiving opioid abatement funds from Tennessee's opioid abatement fund must be paid through a 50% advance payment (for recurring costs like staff wages) and 50% reimbursement grant structure. This applies to nonprofits working on statewide, regional, or local opioid prevention and treatment programs. The bill amends Tennessee law to mandate this payment method, ensuring nonprofits have upfront cash for essential operations while requiring documentation for reimbursement. It directly affects organizations administering opioid-related services funded by the state.
SB 1977 (Tennessee Code Annotated § 40-35-311(h)) modifies probation rules for felony offenders who violate probation by committing a drug offense. It requires trial judges, for the first violation of this type, to order substance abuse treatment instead of revoking probation - based on a preponderance of evidence. This applies directly to individuals on probation for felony drug offenses who breach probation terms. The law takes effect July 1, 2026, and aims to prioritize treatment over immediate probation revocation for first-time violations.
SB 2020 would prevent Tennessee health insurance companies from reducing payments for healthcare services (downcoding) except in specific, limited situations, requiring them to provide the treating provider's identification and credentials when doing so. It extends the validity of prior authorizations for essential treatments like mental health care, cancer therapies, opioid medications, and preventive services, reducing the need for repeated approvals for patients. The bill also prohibits insurers from using artificial intelligence tools alone to deny care, mandating that licensed physicians must review and approve such decisions based on individual patient history. This legislation would directly affect healthcare providers, insurers, and patients in Tennessee by streamlining payment processes and ensuring medical decisions are made by qualified professionals.
HB 2075, the "Helping Open Pathways to Effective (HOPE) Treatment Act," proposes to establish a framework for Tennessee to conduct clinical trials of ibogaine - a Schedule I drug with potential for treating opioid use disorder, PTSD, depression, and other conditions - by amending state laws. The bill creates a process for "cohorts" (groups including drug developers, research institutions, and hospitals) to submit detailed proposals to the Department of Mental Health for FDA-approved trials, requiring specific plans for participant recruitment, safety protocols, and breakthrough therapy designation. It directly affects Tennessee's mental health department, healthcare institutions, and pharmaceutical developers seeking to advance ibogaine research. The bill does not fund trials but enables state participation in federal clinical pathways, aiming to accelerate FDA approval for ibogaine as a medical treatment.
HB 1984 expands access to buprenorphine treatment for opioid use disorder by allowing more healthcare providers to directly administer buprenorphine mono or buprenorphine without naloxone, as long as they act within their scope of practice. It specifically permits prescribing these medications to nursing mothers and patients with documented adverse reactions to naloxone, and clarifies that prescribing injectable forms doesn’t restrict providers from later prescribing non-naloxone buprenorphine. The bill amends Tennessee’s pharmacy law (TCA Title 53, Chapter 11) to remove barriers for these specific scenarios. This directly affects healthcare providers (like nurse practitioners or physician assistants) and patients seeking opioid treatment, particularly nursing mothers and those with allergies to naloxone.
HB 783 authorizes Tennessee local governments (counties, cities, or metropolitan areas) to regulate sober living homes - residences for adults recovering from substance abuse without formal treatment - to ensure they comply with federal fair housing and disability laws. Key provisions include requiring these homes to be at least 1,000 feet from schools/daycares, allowing local zoning rules, and mandating clinical referrals from licensed healthcare providers before residency. The law directly affects sober living home operators, residents, and local governments implementing these rules. It becomes effective immediately upon the governor’s signature (May 21, 2025), updating Tennessee housing codes to balance local oversight with federal civil rights protections.
HB 995 expands Tennessee's law protecting individuals who seek medical help for an overdose to include alcohol-related incidents. It amends state code by replacing "drug overdose" with "overdose" and "drug violation" with "drug or alcohol violation" in immunity provisions. This means people calling for help during an alcohol or drug overdose can no longer face prosecution for minor alcohol or drug offenses related to the incident. The law directly affects individuals experiencing overdoses and those assisting them by seeking emergency care. The bill takes effect on July 1, 2025.
SB 940 expands Tennessee's "Good Samaritan" law to include alcohol-related overdoses, allowing people to seek medical help for alcohol poisoning without facing prosecution for alcohol violations. The bill amends Tennessee Code Annotated Title 63 by updating definitions to replace "drug overdose" with "overdose" and "drug violation" with "drug or alcohol violation" throughout the law. This change directly affects individuals experiencing or witnessing alcohol overdoses, as well as those providing emergency assistance. The policy removes legal barriers to calling for help during alcohol-related medical emergencies, treating alcohol and drug overdoses equally under the immunity provision. The law takes effect July 1, 2025.
